Robin Yang

Robin Yang

Auto-generated profile, based on publicly available information

Robin Yang

YouandMe, New York, NY, United States

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SGSarah M Goodday
Sarah M Goodday
EKEmma Karlin
Emma Karlin
ABAlexa Brooks
Alexa Brooks
CCCarol Chapman
Carol Chapman
CHChristiana Harry
Christiana Harry
SFStephen H Friend
Stephen H Friend
Background: Wearable digital health technologies and mobile apps (personal digital health technologies [DHTs]) hold great promise for transforming health research and care. However, engagement in personal DHT research is poor. Objective: The objective of this paper is to describe how participant engagement techniques and different study designs affect participant adherence, retention, and overall engagement in research involving personal DHTs. Methods: Quantitative and qualitative analysis of engagement factors are reported across 6 unique personal DHT research studies that adopted aspects of a participant-centric design. Study populations included (1) frontline health care workers; (2) a conception, pregnant, and postpartum population; (3) individuals with Crohn disease; (4) individuals with pancreatic cancer; (5) individuals with central nervous system tumors; and (6) families with a Li-Fraumeni syndrome affected member. All included studies involved the use of a study smartphone app that collected both daily and intermittent passive and active tasks, as well as using multiple wearable devices including smartwatches, smart rings, and smart scales. All studies included a variety of participant-centric engagement strategies centered on working with participants as co-designers and regular check-in phone calls to provide support over study participation. Overall retention, probability of staying in the study, and median adherence to study activities are reported. Results: The median proportion of participants retained in the study across the 6 studies was 77.2% (IQR 72.6%-88%). The probability of staying in the study stayed above 80% for all studies during the first month of study participation and stayed above 50% for the entire active study period across all studies. Median adherence to study activities varied by study population. Severely ill cancer populations and postpartum mothers showed the lowest adherence to personal DHT research tasks, largely the result of physical, mental, and situational barriers. Except for the cancer and postpartum populations, median adherences for the Oura smart ring, Garmin, and Apple smartwatches were over 80% and 90%, respectively. Median adherence to the scheduled check-in calls was high across all but one cohort (50%, IQR 20%-75%: low-engagement cohort). Median adherence to study-related activities in this low-engagement cohort was lower than in all other included studies. Conclusions: Participant-centric engagement strategies aid in participant retention and maintain good adherence in some populations. Primary barriers to engagement were participant burden (task fatigue and inconvenience), physical, mental, and situational barriers (unable to complete tasks), and low perceived benefit (lack of understanding of the value of personal DHTs). More population-specific tailoring of personal DHT designs is needed so that these new tools can be perceived as personally valuable to the end user.

22 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TBTina Behrouzi
Tina Behrouzi
JYJennifer Yu
Jennifer Yu
RYRobin Yang
Robin Yang
ABAdrien Boch
Adrien Boch
AGAnna Goldenberg
Anna Goldenberg
SFStephen H. Friend
Stephen H. Friend
Background: Personal digital health technologies (DHTs) enable real-time monitoring of physiological metrics and behavioral data, including HRV, supporting early detection of pregnancy-related conditions and personalized care throughout the perinatal period. While recent studies demonstrate the utility of personal DHTs in tracking pregnancy-related symptoms, they often rely on aggregate statistical methods that overlook individual variability. Objective: To compare aggregate and individual-level analyses of digital health technology (DHT) data for early detection of pregnancy-related conditions, using the comprehensive BUMP dataset to highlight the importance of individual variability and data heterogeneity. Methods: This BUMP study (Jan 2021 – May 2022) analyzed physiological and behavioral metrics, such as heart rate variability (HRV), sleep, and fatigue, in 256 individuals using Oura rings and self-reported surveys. Individual-level (N-of-1) trajectories were evaluated and compared with aggregate results to uncover personal and collective trends. A statistical method was developed to assess the influence of adverse events and severe symptoms, while case studies explored confounding and modifying factors underlying heterogeneity. Comprehensive statistical analysis included the coefficient of determination, Kolmogorov-Smirnov tests, likelihood ratio tests, and Welch’s t-tests, with inter-individual variability flagged based on high-variability thresholds. Results: Results revealed significant variability in HRV, sleep, and fatigue throughout pregnancy. For instance, only 4.76% of individuals had HRV inflection points at the aggregate week 33 inflection, with a 14.24% coefficient of variation. Our analysis found no significant p-values for demographic or pregnancy complication-based subgrouping, suggesting these factors alone do not drive the observed variability. Case studies further highlighted both intra- and inter-individual differences, emphasizing the importance of considering external factors like adverse events and severe symptoms. Conclusions: Our findings show that aggregate wearable data often fails to generalize across populations, oversimplifying pregnancy-related physiological and subjective changes. This simplification can obscure individual trajectories, leading to generalized insights that may not reflect many pregnant women’s experiences. Our results highlight the impact of heterogeneity on pregnancy outcomes, emphasizing the need to move beyond one-size-fits-all models and leverage DHT for personalized care.

20 October 2025 in JMIR Formative Research
Verified
Journal Article
Open access
TBTina Behrouzi
Tina Behrouzi
JYJennifer Yu
Jennifer Yu
RYRobin Yang
Robin Yang
ABAdrien Boch
Adrien Boch
AGAnna Goldenberg
Anna Goldenberg
SFStephen H. Friend
Stephen H. Friend
Personal digital health technologies (DHTs) enable real-time monitoring of physiological metrics and behavioral data, including heart rate variability (HRV), supporting analysis of pregnancy-related conditions and personalized care throughout the perinatal period. While recent studies demonstrate the utility of personal DHTs in tracking pregnancy-related symptoms, they often rely on aggregate statistical methods that overlook individual variability. This study aims to compare aggregate and individual-level analyses of DHT data for pregnancy-related conditions, using the comprehensive BUMP (Better Understanding the Metamorphosis of Pregnancy) dataset to highlight the importance of individual variability and data heterogeneity. We analyzed wearable and self-reported data from 256 participants enrolled in the BUMP study (January 2021 to May 2022), including HRV, sleep, and fatigue measured via Oura Rings and smartphone surveys. Individual-level (N-of-1) trajectories were evaluated and compared with aggregate results to uncover personal and collective trends. A statistical method was developed to assess the influence of adverse events and severe symptoms, while case studies explored confounding and modifying factors underlying heterogeneity. Comprehensive statistical analysis included the coefficient of determination, Kolmogorov-Smirnov tests, likelihood ratio tests, and Welch t tests, with interindividual variability flagged based on high-variability thresholds. Substantial interindividual variability was observed across all features. Only 4.76% (12/256) of participants exhibited an HRV inflection at the aggregate week-33 inflection point, with a coefficient of variation of 14.24%. The median value of the gestational week in individual fatigue troughs was 23 (IQR 8; range 8-38) weeks, differing from aggregate estimates. Distributional comparisons showed no statistically significant differences in individual-level model fit (R²) by pregnancy complications or age (P values ranging from .06 to .99 across all model fit comparisons). Case studies further highlighted both intraindividual and interindividual differences, emphasizing the importance of considering external factors, such as adverse events and severe symptoms. Our findings show that aggregate wearable data often fail to generalize across populations, oversimplifying pregnancy-related physiological and subjective changes. This simplification can obscure individual trajectories, leading to generalized insights that may not reflect many pregnant women's experiences. Our results highlight the impact of heterogeneity on pregnancy outcomes, emphasizing the need to move beyond one-size-fits-all models and leverage DHT for personalized care.

20 July 2026 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SGSarah Margaret Goodday
Sarah Margaret Goodday
EKEmma Karlin
Emma Karlin
MSMadeleine Sorensen
Madeleine Sorensen
RYRobin Yang
Robin Yang
PGPaul Gordon
Paul Gordon
SFStephen Friend
Stephen Friend
Background: End user co-design in the personal digital health technology space is underdeveloped. Clinical uptake of personal digital health technologies has been poor, highlighting a need to cocreate solutions with end users. Objective: The study aimed to describe an “end user” co-design framework in the development of 5 prototype personal health apps for patients with different rare or complex diseases. Methods: A patient-led, user-centered, collaborative personal health app plus wearable plug-in co-design methodology was developed. Five prototype apps were developed for end users with long COVID-19, pancreatitis, primary ciliary dyskinesia, sarcoidosis, and valosin-containing protein disease by a multidisciplinary partnership including patients, app design and development experts, user experience experts, clinicians, and patient-driven organizations. Phase 1 involved a 6-month co-design process with 5 modules involving patient-driven organizations that included the codevelopment of specifications through group workshops and independent exercises that defined the goals, content, features, and user experience of each app. Phase 2 involved app build-out, internal alpha testing, and beta study preparations. Phase 3 involved a usability beta testing study in which end users used the app and associated wearable/smart devices (Oura ring, Lumia ear device, Empatica EmbracePlus, and MIR Spirobank Spirometer) for up to 5 months. Participant feedback was documented continuously and systematically, centering on the following themes: functionality, usability, harms, benefits, self-explorations, and beta testing study details related to retention and adherence. Results: While unique app goals were codeveloped by each disease group, a central goal across groups was to develop a personal health app enabling users to track subjective, self-reported symptoms, objective measures of health, and unique modifiers of symptoms. A total of 239 end user participants participated in the beta testing pilot study. Enrollment and retention rates were high, ranging from 94% to 100% and 92.2% to 100%, respectively. All active participants gave some form of feedback: there were 257 unique participant suggestions of how to specifically modify or improve the study app experience. Participant feedback themes commonly centered around customization to reduce daily burden and improve personal tailoring of the app. Participants’ desires surrounding symptom displays were heterogeneous. Conclusions: Personal health app co-design is rooted in a complex digital landscape that requires a significant amount of up-front effort and time. However, the up-front investment of time can result in rich and diverse end user feedback that could save time in the app development trajectory to implementation. This paper provides a co-design framework and the building blocks of 5 prototype personal health apps with publicly available open-source code on GitHub. These prototypes could be leveraged for improving understanding of, communicating symptoms of, and providing n-of-1 suggestions for rare or complex diseases, providing benefit to patient communities and individual patients.

20 October 2025 in JMIR Preprints
Verified
Preprint
Open access
TBTina Behrouzi
Tina Behrouzi
JYJennifer Yu
Jennifer Yu
RYRobin Yang
Robin Yang
ABAdrien Boch
Adrien Boch
AGAnna Goldenberg
Anna Goldenberg
SFStephen H. Friend
Stephen H. Friend
BACKGROUND Personal digital health technologies (DHTs) enable real-time monitoring of physiological metrics and behavioral data, including HRV, supporting early detection of pregnancy-related conditions and personalized care throughout the perinatal period. While recent studies demonstrate the utility of personal DHTs in tracking pregnancy-related symptoms, they often rely on aggregate statistical methods that overlook individual variability. OBJECTIVE To compare aggregate and individual-level analyses of digital health technology (DHT) data for early detection of pregnancy-related conditions, using the comprehensive BUMP dataset to highlight the importance of individual variability and data heterogeneity. METHODS This BUMP study (Jan 2021 – May 2022) analyzed physiological and behavioral metrics, such as heart rate variability (HRV), sleep, and fatigue, in 256 individuals using Oura rings and self-reported surveys. Individual-level (N-of-1) trajectories were evaluated and compared with aggregate results to uncover personal and collective trends. A statistical method was developed to assess the influence of adverse events and severe symptoms, while case studies explored confounding and modifying factors underlying heterogeneity. Comprehensive statistical analysis included the coefficient of determination, Kolmogorov-Smirnov tests, likelihood ratio tests, and Welch’s t-tests, with inter-individual variability flagged based on high-variability thresholds. RESULTS Results revealed significant variability in HRV, sleep, and fatigue throughout pregnancy. For instance, only 4.76% of individuals had HRV inflection points at the aggregate week 33 inflection, with a 14.24% coefficient of variation. Our analysis found no significant p-values for demographic or pregnancy complication-based subgrouping, suggesting these factors alone do not drive the observed variability. Case studies further highlighted both intra- and inter-individual differences, emphasizing the importance of considering external factors like adverse events and severe symptoms. CONCLUSIONS Our findings show that aggregate wearable data often fails to generalize across populations, oversimplifying pregnancy-related physiological and subjective changes. This simplification can obscure individual trajectories, leading to generalized insights that may not reflect many pregnant women's experiences. Our results highlight the impact of heterogeneity on pregnancy outcomes, emphasizing the need to move beyond one-size-fits-all models and leverage DHT for personalized care.